Kanakasetty S. Babu-Govind
Bengaluru, KA 560027, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer.
Journal: ESMO open
Published: March 20, 2023
Drug susceptibility testing of circulating lung cancer cells for personalized treatment.
Journal: Medical oncology (Northwood, London, England)
Published: May 04, 2022
"Choosing Wisely" for Cancer Care in India.
Journal: Indian journal of surgical oncology
Published: March 25, 2020
A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial.
Journal: Leukemia & lymphoma
Published: February 29, 2020
A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial.
Journal: British journal of haematology
Published: January 21, 2020
Correlation of BMI with breast cancer subtype and tumour size.
Journal: Ecancermedicalscience
Published: February 03, 2018
Epidemiology and Outcomes with Platinum-Based Chemotherapy in Recurrent or Metastatic Carcinoma Cervix in a Developing Country: Experience from a Tertiary Oncology Centre in Southern India.
Journal: The Gulf journal of oncology
Published: July 18, 2017
Health-related quality of life and patient-reported outcomes of ofatumumab plus fludarabine and cyclophosphamide versus fludarabine and cyclophosphamide in the COMPLEMENT 2 trial of patients with relapsed CLL.
Journal: Leukemia & lymphoma
Published: November 11, 2016
Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial.
Journal: Leukemia & lymphoma
Published: October 13, 2016
Last Updated: 09/26/2026